Eli Lilly is a big company that makes medicine to help people with diabetes and obesity. Diabetes is when your body can't use sugar properly, and obesity is when you weigh too much because of extra fat. Eli Lilly has been doing very well lately because more people need their medicines. They expect to make even more money in the next few years. This is good for them because they can keep making new medicines to help more people. Read from source...

1. The headline is misleading and exaggerated. It implies that Eli Lilly is solely dependent on the diabetes and obesity drug boom, which is not true. The company has a diversified portfolio of products and services across different therapeutic areas. A more accurate headline would be "Eli Lilly Benefits From Diabetes And Obesity Drug Boom, Projects 20% Revenue Increase In 2024".